Myriad Genetics Reports Unauthorized IT Network Access
Myriad Genetics experienced unauthorized access to its IT network on November 2, 2026, leading to a temporary suspension of testing and order management systems.
Stocks · News reference
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
Myriad Genetics, Inc. announced its scheduled participation in three upcoming investor healthcare conferences in November 2026.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
TD Cowen Maintains Hold on Myriad Genetics, Raises Price Target to $6.75
Leerink Partners Maintains Market Perform on Myriad Genetics, Raises Price Target to $8
Myriad Genetics Detects Unauthorized Access In It Network On Nov. 2; Temporarily Suspended Testing Operations, Order Management Systems Due To Incident; Probing Potential Access To Patient Records
8-K filing — MYRIAD GENETICS INC (MYGN)
Filed: 2026-11-05 AccNo: 0001628280-26-070659 Size: 166 KB Item 8.01: Other Events
Myriad Genetics Reports Third Quarter 2026 Financial Results and Raises Full-Year Revenue Guidance
Myriad Genetics announced its financial results for the third quarter ended September 30, 2026, and increased the mid-point of its full-year 2026 revenue guidance.